Press Releases
Abbott laboratories says U.S. FDA approves tecnis symfony intraocular...
Approval includes toric version of symfony iol for people with astigmatism lenses provide high-quality continuous vision so patients can see clearly at near, intermediate...
Press Releases
Dailies Total1 Multifocal contact lenses launched for presbyopia- Alcon
Alcon, the global leader in eye care and a division of Novartis, introduces Dailies Total1 Multifocal contact lenses for people with presbyopia. This innovative multifocal...
Press Releases
Boehringer Ingelheim and University of Dundee collaborate to develop...
Collaboration aims to develop PROteolysis TArgeting Chimeric molecules (PROTACs) – a new therapeutic modality that is able to degrade proteins playing a central role...
Press Releases
Health Canada approves Abbott’s Absorb Bioresorbable Stent
Revolutionary Device Made Of Naturally Dissolving Material, Similar To Dissolving Sutures Treats Coronary Artery Disease Like A Metallic Stent, But Then Disappears...
Press Releases
Sandoz Biosimilar Etanercept Recommended By US FDA For Approval...
Sandoz, a Novartis division and leader in biosimilars, announced that the US FDA Advisory Committee recommended approval of its proposed biosimilar etanercept. The committee voted...
Press Releases
U.S. FDA Grants Priority Review to Janssen’s New Drug...
Janssen Pharmaceuticals, Inc announced that the U.S. FDA has granted Priority Review designation for the NDA for a 500mg chewable tablet formulation of mebendazole. Â If...
Press Releases
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars...
Amgen and Daiichi Sankyo Company, Limited announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.